Sellas Life Sciences Group, Inc.
SEC CIK 1390478 · gale · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Stergiou Angelos M. | Director · President and CEO | filed 2017 - 2026 |
| VAN Nostrand Robert L | Director | filed 2017 - 2026 |
| Scheinberg David A | Director | filed 2017 - 2026 |
| Wasman Jane | Director | filed 2017 - 2026 |
| Varian John | Director | filed 2017 - 2026 |
| Kalin Katherine Bach | Director | filed 2022 - 2026 |
| Ghiglieri Stephen F | Director · Chief Financial Officer | filed 2016 - 2019 |
| Lopez Fabio | Director | filed 2017 - 2018 |
| Galliker Stephen S | Director | filed 2008 - 2017 |
| Gray Mary ANN | Director | filed 2016 - 2017 |
| Hillsberg Sanford | Director | filed 2008 - 2017 |
| Nisi Rudolph | Director | filed 2009 - 2017 |
| Chin Richard | Director | filed 2009 - 2017 |
| Ashton William | Director | filed 2013 - 2017 |
| Einhorn Irving M. | Director | filed 2014 - 2017 |
| Schwartz Mark W. | Director · President and CEO | filed 2011 - 2016 |
| Kriegsman Steven A | Director | filed 2008 - 2015 |
| Ahn Mark J | Director · President and CEO | filed 2008 - 2014 |
| Beerman Noah D | Director · CEO and President | filed 2009 - 2011 |
| Woolf Tod | Director · President and CEO | filed 2008 - 2009 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Cicic Dragan | SVP, Chief Development Officer | filed 2024 - 2026 |
| Burns John Thomas | Vice President, Finance | filed 2016 - 2026 |
| Wood Barbara A | EVP, Gen. Counsel, Corp. Sec. | filed 2018 - 2024 |
| Francomano Robert | Chief Commercial Officer | filed 2022 - 2024 |
| Sarlis Nicholas J. | Chief Medical Officer and SVP | filed 2017 - 2019 |
| Mack Gene | CFO and Treasurer | filed 2018 - 2018 |
| Torre Gregory M | CRO and SVP | filed 2017 - 2018 |
| Krylov Aleksey N. | Interim CFO | filed 2017 - 2017 |
| Knapp Thomas J c/o Sucampo Pharmaceuticals, Inc. | General Counsel | filed 2015 - 2017 |
| Nejadnik Bijan | Executive VP and CMO | filed 2015 - 2017 |
| Dunlap Ryan | VP, Chief Financial Officer | filed 2012 - 2016 |
| Kivinski Margaret | VP and General Counsel | filed 2014 - 2015 |
| Hamilton Brian L | EVP, Chief Medical Officer | filed 2013 - 2014 |
| Mazanet Rosemary | Chief Medical Officer | filed 2012 - 2013 |
| Lee Kwang | Principal Accounting Officer | filed 2011 - 2011 |
| Pavco Pamela | VP of Pharmaceutical Devlpmt. | filed 2008 - 2011 |
| Khvorova Anastasia | Chief Scientific Officer | filed 2008 - 2011 |
| Kennedy Robert Eugene | Vice President and CFO | filed 2011 - 2011 |
| Varanasi Ramani | VP, Business Development | filed 2009 - 2011 |
| Tata Amy B | Principlw Acctg Officer & Cont | filed 2009 - 2011 |
| Andrikopoulos Konstantinos | VP, Legal | filed 2008 - 2010 |
| Samarsky Dmitry | VP, Technology Development | filed 2008 - 2010 |
| Dipalma Stephen J. | CFO, EVP, Secretary | filed 2008 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.